ATE314474T1 - Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen. - Google Patents

Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.

Info

Publication number
ATE314474T1
ATE314474T1 AT93913130T AT93913130T ATE314474T1 AT E314474 T1 ATE314474 T1 AT E314474T1 AT 93913130 T AT93913130 T AT 93913130T AT 93913130 T AT93913130 T AT 93913130T AT E314474 T1 ATE314474 T1 AT E314474T1
Authority
AT
Austria
Prior art keywords
protein
cloning
gene
peptide fragments
gondii
Prior art date
Application number
AT93913130T
Other languages
English (en)
Inventor
Marie-France Cesbron
Corinne Mercier
Andre Capron
Andre Tartar
Pierrette Maes
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE314474T1 publication Critical patent/ATE314474T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93913130T 1992-06-15 1993-06-15 Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen. ATE314474T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9207206A FR2692282B1 (fr) 1992-06-15 1992-06-15 Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
PCT/FR1993/000575 WO1993025689A1 (fr) 1992-06-15 1993-06-15 Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications

Publications (1)

Publication Number Publication Date
ATE314474T1 true ATE314474T1 (de) 2006-01-15

Family

ID=9430735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913130T ATE314474T1 (de) 1992-06-15 1993-06-15 Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.

Country Status (8)

Country Link
US (2) US5824788A (de)
EP (1) EP0648270B1 (de)
JP (1) JPH07507453A (de)
AT (1) ATE314474T1 (de)
CA (1) CA2137280C (de)
DE (1) DE69333952D1 (de)
FR (1) FR2692282B1 (de)
WO (1) WO1993025689A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665542A (en) * 1989-11-03 1997-09-09 Research Institute Of Palo Alto Medical Foundation Toxoplasma gondii P28 gene and methods for its use
FR2692282B1 (fr) * 1992-06-15 1995-07-13 Pasteur Institut Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
ZA958366B (en) * 1994-10-06 1996-04-24 Akzo Nobel Nv New toxoplasma gondii antigens
CA2224723A1 (en) * 1995-06-16 1997-01-03 Peter J. Nelson Novel enhancer sequences for late t cell expressed genes
EP0953641A3 (de) * 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
US6902926B1 (en) * 2000-11-09 2005-06-07 University Of Vermont And State Agricultural College Toxoplasma gondii apical membrane antigen-1
BR0200690A (pt) * 2002-03-04 2004-03-23 Embrapa Pesquisa Agropecuaria Método para detecção de proteinas de origem em misturas complexas
AU2003219541A1 (en) * 2002-03-21 2003-10-08 Kenton S.R.L. Antigen fragments for the diagnosis of toxoplasma gondii
EP1507004A1 (de) * 2003-08-14 2005-02-16 DKFZ Deutsches Krebsforschungszentrum Verfahren zur Inhibierung der Vermehrung unerwünschter Zellpopulationen
KR20080003330A (ko) * 2005-03-08 2008-01-07 켄톤 에스.알.엘. 톡소포자충의 키메릭 재조합 항원
CN103517714A (zh) * 2010-12-23 2014-01-15 英珀特疗法有限公司 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物
FR2996918B1 (fr) * 2012-10-16 2015-07-03 Univ Grenoble 1 Antigenes gra recombinants et leur application pour le diagnostic precoce de la toxoplasmose

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (de) * 1989-12-08 1991-06-13 Behringwerke Ag Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
DE68926658T2 (de) * 1988-03-09 1996-11-28 Univ Leland Stanford Junior Diagnostische gene zum nachweis von toxoplasmose
US5665542A (en) * 1989-11-03 1997-09-09 Research Institute Of Palo Alto Medical Foundation Toxoplasma gondii P28 gene and methods for its use
FR2692282B1 (fr) * 1992-06-15 1995-07-13 Pasteur Institut Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.

Also Published As

Publication number Publication date
CA2137280C (fr) 2005-12-27
WO1993025689A1 (fr) 1993-12-23
US5824788A (en) 1998-10-20
FR2692282B1 (fr) 1995-07-13
JPH07507453A (ja) 1995-08-24
US6392014B1 (en) 2002-05-21
EP0648270B1 (de) 2005-12-28
CA2137280A1 (fr) 1993-12-23
FR2692282A1 (fr) 1993-12-17
EP0648270A1 (de) 1995-04-19
DE69333952D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
DK0758383T3 (da) Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
CO5050400A1 (es) Proteina de chlamydia, secuencia de genes y anticuerpos para ello
DE69636450D1 (de) PEPTIDE UND PEPTIDOMIMETIKA MIT STRUKTURELLER ÄHNLICHKEIT MIT p53 UND DIE DIE p53-FUNKTION AKTIVIEREN
NO971875L (no) Cathepsin 02 protease
ATE295736T1 (de) Verwendung von interleukin-15
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
DE69715181T2 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
ATE147100T1 (de) Ehv-4 glykoprotein vazin
ATE385805T1 (de) Neue peptide
GR3021660T3 (en) Anticoagulant peptides
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
IT1284870B1 (it) Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
BG102937A (en) Zona pelucida proteins as contraceptives
SE9604439D0 (sv) New receptor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties